The independent source for health policy research, polling, and news.
35,181 - 35,200 of 112,564 Results
As Americans' views have evolved in regard to how cancer is tackled and treated, so has the language we use to discuss it. Meanwhile, a cooling cap device helps patients retain their hair during chemotherapy and a study finds that optimistic women are less likely to get cancer.
And as Florida reports that the virus is no longer actively transmitting in Miami Beach zones, Texas officials confirm four new locally acquired cases of Zika.
Leaders in San Antonio have acted aggressively and spent heavily to try to address mental health issues in their community.
The federal government recoups the cost of insuring low-income children because they grow up to be healthier and pay more in taxes and use fewer public benefits, according to the study published by the nonpartisan National Bureau of Economic Research.
Supporters tout the legislation as a way to fundamentally change the way diseases are treated in this country, but its critics are less than impressed.
"This is the strongest the pro-life movement has been since 1973,” said Marjorie Dannenfelser, the president of the Susan B. Anthony List. A renewed push for "personhood" laws is expected to be one of its first moves.
The drug industry has been trying to gain control of the story — such as pledging to limit price increases — so that it can protect itself from attacks that might come from the incoming president. Meanwhile, some Republicans champion importing drugs to help cut down on costs and, following the EpiPen controversy, a watchdog agency reviews others in the drug rebate program.
Rep. Tom Price has received thousands in campaign dollars from the very companies and organizations that will be the most affected by his choices as the anticipated secretary of HHS. And KHN reports on five moves Price could quickly make that would have strong policy ramifications.
The insurance industry is built around advanced planning and detailed projections of risk, and the companies are worried they're going to be left without any rules of the road to follow. Meanwhile, in other news, Republicans' plan to have insurers sell across state lines comes under fire; Aetna's CEO says decision to leave health law market was not driven by the DOJ's lawsuit; the medical device tax may end under a Trump presidency; and Labor secretary nominee's opinion on the health law's impact on restaurants is challenged.
No major industry executives, patients and doctors groups nor insurers who have been critics of the health law are voicing support for the Republicans' strategy. On the contrary, most warn that it will be disastrous. Meanwhile, to save the insurance market from collapsing amid uncertainty, Republicans may have to rely on the "bailouts" they so hated during the Obama administration.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Outlets report on health news from Georgia, Arizona, Colorado, Pennsylvania, Minnesota, Maryland, Ohio, Florida and California.
A report released by the National Center for Transgender Equality shows that many still struggle with bias and prejudice that negatively affects their mental health, despite gains in transgender rights in the past few years.
Rep. Tom Price, Donald Trump's pick to head HHS, has twice co-sponsored federal legislation that would define fertilized human eggs as legal persons — one of which Vice President-elect Mike Pence co-sponsored.
The VA determines the ratings for 146 of its medical centers each quarter and bases them on dozens of factors, including death and infection rates, instances of avoidable complications and wait times.
Evergreen, which started as one of the health co-op insurers funded by the federal health law, ran into financial problems. Insurance regulators had hoped that it would work through the regulatory process for its conversion in time for the beginning of 2017 coverage, but it didn't manage to do so.
At the ongoing antitrust trial, Justice officials raise concerns about the ability of Molina Healthcare, the proposed asset buyer, to keep the marketplace competitive for private Medicare plans.
CMS releases the list of drugs that contributed to higher Medicare spending in 2015. Meanwhile, payers predict drug prices will continue to rise between 3 and 6 percent over the next three years.
© 2026 KFF